Skip to content

Moderate Bleeding in Cardiac Surgery Post Operative

Bleeding Moderate Postoperative Cardiac Surgery and Prognostic Implications Anemia and Postoperative Transfusion: Prospective, Observational, Descriptive.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02712879
Acronym
SPO
Enrollment
303
Registered
2016-03-18
Start date
2016-03-11
Completion date
2016-06-30
Last updated
2022-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Surgery

Brief summary

Determine a bleeding threshold by measuring the blood volume in ml / kg / h collected in the drainage system to define moderate bleeding postoperative cardiac surgery and define the population.

Detailed description

Determine a bleeding threshold by measuring the blood volume in ml / kg / h collected in the drainage system to define moderate bleeding postoperative cardiac surgery and define the population. Secondary objectives: To evaluate the kinetics of moderate SPORT and its impact on anemia and postoperative transfusion. To evaluate the prognostic impact of the SPO moderate in terms of post-operative complications. Determine predictors of moderate SPO.

Interventions

None listed

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Patients in the postoperative intensive care in cardiac surgery

Exclusion criteria

* Patients who received a heart transplant, a heart surgery beating, cardiac support establishment of long duration, or have a disease that alters the coagulation.

Design outcomes

Primary

MeasureTime frameDescription
Evolution of blood loss per hour drainsHourly blood loss in drains during the first twelve hoursHourly blood loss in drains during the first twelve hours

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026